Cutaneous T-Cell Lymphoma clinical trials at UC Irvine
2 in progress, 0 open to eligible people
Showing trials for
Mogamulizumab Q4week Dosing in Participants With R/R CTCL
Sorry, in progress, not accepting new patients
This is an open-label, multicenter, Phase 2 study to evaluate the safety and tolerability of mogamulizumab given Q4W following initial weekly induction in adult participants with relapsed/refractory MF and SS subtypes of CTCL. The study is composed…
Irvine, California and other locations
PK, PD, Clinical Activity of KT-333 in Adult Patients with Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Sorry, in progress, not accepting new patients
This Phase 1a/1b study will evaluate the safety, tolerability and the pharmacokinetics/pharmacodynamics (PK/PD) of KT-333 in Adult patients with Relapsed or Refractory (R/R) Lymphomas, Large Granular Lymphocytic Leukemia (LGL-L), T-cell…
Orange, California and other locations
Last updated: